Global 500
AbbVieRANK378
The Illinois-based biopharmaceutical firm is off to a good start in 2020, thanks in part to record sales of the world’s best-selling drug, Humira, which can be used to treat a wide range of ailments including arthritis and Crohn's disease. While the growth of biosimilar drugs threatens its Humira franchise in the long term, AbbVie is nurturing other potential blockbusters, including plaque-psoriasis therapy Skyrizi. The company also received FDA approval to acquire Botox-maker Allergan, which will provide a booster shot to revenue. AbbVie noted the pandemic has reduced prescriptions as a result of a decline in doctor’s office visits, but said it expects this trend to reverse in coming months.
Courtesy of AbbVie
Lists ranking AbbVie
RANK58
100 Best Companies to Work For - 2021Our 2021 list of the 100 best companies to work fo...view in list
RANK3
20 Best Workplaces in Biotechnology and Pharmaceuticals - 2021The best U.S. biotechnology and pharmaceutical com...view in list
World’s Most Admired Companies - 2021After a year in which humanity leaned more heavily...view in list
RANK67
75 Best Large Workplaces for Women - 2020The companies on this year's list make a conscious...view in list
RANK43
75 Best Large Workplaces for Millennials - 2020We surveyed tens of thousands of young employees t...view in list
Latest news for AbbVie
- MagazineBig Hospitals vs. Big Pharma: Which industry is most to blame for soaring health care costs?April 8, 2021 10:30 AM UTC
- HealthIt’s the New Year, and pharma companies are already hiking prices for popular drugsJanuary 4, 2021 8:35 PM UTC
- MPWThree more women have died from cancer linked to Allergan’s recalled breast implants, FDA saysAugust 24, 2020 4:48 PM UTC
- Magazine‘They killed her’: Why are breast implants still putting millions of women at risk?May 18, 2020 9:00 AM UTC